Brief: Bellerophon Therapeutics Announces Publication Of Cohort 1 Of Ino-Pf Phase 2/3 Study In The Chest Journal
15/07/2020 13:36
July 15 (Reuters) - Bellerophon Therapeutics Inc BLPH.O :
* BELLEROPHON THERAPEUTICS ANNOUNCES PUBLICATION OF COHORT 1
OF
INO-PF PHASE 2/3 STUDY IN THE CHEST JOURNAL AND PARTICIPATION IN
WEBINAR TO DISCUSS CLINICAL RESULTS
* BELLEROPHON THERAPEUTICS INC - PATIENTS TREATED WITH
INOPULSE®
DEMONSTRATED IMPROVED PHYSICAL ACTIVITY COMPARED TO PLACEBO
Source text for Eikon: ID:nGNX9HygNg
Further company coverage: BLPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellerophon Therapeutics
See all newsBrief: Bellerophon Therapeutics Inc On October 12, 2023, Board Of Directors Approved Plan Of Liquidation And Dissolution Of Company
Bellerophon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Bellerophon Therapeutics Inc expected to post a loss of 42 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Archer-Daniels-Midland, Nucor, Copper miners
U.S. STOCKS ON THE MOVE-Hubbell, Spire Global, FibroGen